Decompensated Heart Failure Clinical Trials
2 recruiting trials for Decompensated Heart Failure. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Decompensated Heart Failure clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Beni-Suef University (1), Biotronik SE & Co. KG (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Inspiratory Muscle Trainer (device, 1 trial), followed by Functional Electrical Stimulation, Standard medical treatment.
Track Decompensated Heart Failure trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Cardiac Rehabilitation in Decompensated Heart Failure
Heart failure is a common clinical condition that often leads to reduced exercise tolerance, shortness of breath, and poor quality of life. Many patients with heart failure also...
BIO|CONCEPT.BIOMONITOR-HF Collect Clinical Data From Heart Failure Patients Using BIOMONITOR Devices With a Study...
\[Plain language\]: Heart failure (HF) patients often experience irregular heartbeats, known as arrhythmias. Atrial fibrillation (AF) is common among HF patients and can worsen...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Decompensated Heart Failure, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Decompensated Heart Failure, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Decompensated Heart Failure, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.